Aurobindo Pharma Ltd

is a top Indian pharmaceutical exporter, with strong US and European generics businesses and backward-integrated manufacturing. The company’s product pipeline, focus on complex generics, and expansion into injectables drive future growth. It generates healthy cash flows but faces market headwinds from US price erosion and regulatory challenges at manufacturing sites. Investments in specialty drugs and biosimilars are critical for the next growth cycle.